LANTERN PHARMA INC.

Insiders Lantern Pharma Inc.

Equities

LTRN

US51654W1018

Delayed Nasdaq Other stock markets 03:55:45 2024-04-30 pm EDT			5-day change	1st Jan Change
5.095 ^USD	+3.35%		-11.70%	+19.04%

Apr. 24	Transcript : Lantern Pharma Inc. - Special Call
Apr. 22	Lantern Gets Regulatory Approval in Japan, Taiwan for Non-Small Cell Lung Cancer Trial Expansion	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lantern Pharma Inc. Announces the Death of Dr. Franklyn Prendergast, a Director of the Company	23-10-20	CI
Lantern Pharma Inc. Appoints Ernest Kitt as Head of Clinical Operations	23-03-02	CI
Insider Sell: Lantern Pharma	22-11-10	MT
Lantern Pharma Inc. Announces Leslie W. Kreis, Jr. Not to Stand for Reelection as A Director	22-04-26	CI
Lantern Pharma Appoints Harry Kochat as Senior Director of Chemistry, Manufacturing and Controls and Manufacturing Quality Affair	21-09-02	CI
Lantern Pharma Inc. Announces Executive Changes	19-12-17	CI
Lantern Pharma Announces Board Appointments	19-12-11	CI
Lantern Pharma Inc. Appoints Jeff Keyser to its Board of Directors	17-01-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer